Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine
- 713 Downloads
The paper is motivated by severe concerns regarding currently applied care of the pregnancy-associated breast cancer (PABC) characterised by particularly poor outcomes of the disease. Psychological and ethical aspects play a crucial role in PABC: the highest priority not to damage the foetus significantly complicates any treatment generally, and it is quite usual that patients disclaim undergoing any breast cancer treatment during pregnancy. Although, due to global demographic trends, PABC is far from appearing rarely now, severe societal and economic consequences of the disease are still neglected by currently applied reactive medical approach. These actualities require creating new strategies which should be better adapted to the needs of the society at large by advancing the PABC care based on predictive diagnostic approaches specifically in premenopausal women, innovative screening programmes focused on young female populations, targeted prevention in high-risk groups, and optimised treatment concepts. The article summarises the facts and provides recommendations to advance the field-related research and medical services specifically dedicated to the PABC care.
KeywordsPredictive preventive personalised medicine Breast cancer Pregnancy Risk assessment Multi-level diagnostics Recommendations
OG is the project coordinator who has created the main scientific concepts presented in the manuscript. JP Jr. has performed the literature search, analysed the data, and drafted the manuscript. IA has contributed to the literature search, data collection and analysis and concepts’ development. OG and JP Jr. have designed the final version of the manuscript.
This work was supported by the Charles University Research Fund (Progres Q39), by the MH CZ - DRO (Faculty Hospital Plzen - FNPl, 00669806), and by the National Sustainability Program I (NPU I) Nr. LO1503 provided by the Ministry of Education Youth and Sports of the Czech Republic. The authors thank the European Association for Predictive, Preventive and Personalised Medicine (EPMA, Brussels) for professional and financial support of the project.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of informed consent
Patients have not been involved in the study.
Statement of human and animal rights
No experiments have been performed including patients and/or animals.
- 2.Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V, et al. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumour Biol. 2016;37(10):12941–57. https://doi.org/10.1007/s13277-016-5168-x.PubMedCrossRefGoogle Scholar
- 4.Kim YG, Jeon YW, Ko BK, Sohn G, Kim E-K, Moon B-I, et al. Clinicopathologic characteristics of pregnancy-associated breast cancer: results of analysis of a nationwide breast cancer registry database. J Breast Cancer. 2017;20(3):264–9. https://doi.org/10.4048/jbc.2017.20.3.264.PubMedPubMedCentralCrossRefGoogle Scholar
- 5.Langer A, Mohallem M, Stevens D, Rouzier R, Lerebours F, Chérel P. A single-institution study of 117 pregnancy-associated breast cancers (PABC): presentation, imaging, clinicopathological data and outcome. Diagn Interv Imaging. 2014;95(4):435–41. https://doi.org/10.1016/j.diii.2013.12.021.PubMedCrossRefGoogle Scholar
- 11.American College of Pediatrics - December 2013. Information for the adolescent woman and her parents: abortion and the risk of breast cancer. Issues Law Med. 2017;32:99–104.Google Scholar
- 12.Hou N, Ogundiran T, Ojengbede O, Morhason-Bello I, Zheng Y, Fackenthal J, et al. Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study. Ann Epidemiol. 2013;23(9):551–7. https://doi.org/10.1016/j.annepidem.2013.06.008.PubMedPubMedCentralCrossRefGoogle Scholar
- 18.Callihan EB, Gao D, Jindal S, Lyons TR, Manthey E, Edgerton S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat. 2013;138(2):549–59. https://doi.org/10.1007/s10549-013-2437-x.PubMedPubMedCentralCrossRefGoogle Scholar
- 25.| Human Development Reports [Internet]. [cited 2018 Jan 2]. Available from: http://hdr.undp.org/en/2016-report.
- 34.Rapacz-Leonard A, Dąbrowska M, Janowski T. Major histocompatibility complex I mediates immunological tolerance of the trophoblast during pregnancy and may mediate rejection during parturition. Mediat Inflamm. 2014;2014:579279.Google Scholar
- 35.O’Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, et al. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol. 2010;176(3):1241–55. https://doi.org/10.2353/ajpath.2010.090735.PubMedPubMedCentralCrossRefGoogle Scholar
- 36.Strange R, Li F, Saurer S, Burkhardt A, Friis RR. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Dev Camb Engl. 1992;115:49–58.Google Scholar
- 37.Strange R, Metcalfe T, Thackray L, Dang M. Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech. 2001;52(2):171–81. https://doi.org/10.1002/1097-0029(20010115)52:2<171::AID-JEMT1003>3.0.CO;2-T.PubMedCrossRefGoogle Scholar
- 42.Stolzenburg-Veeser L, Golubnitschaja O. Mini-encyclopaedia of the wound healing—opportunities for integrating multi-omic approaches into medical practice. J Proteomics. 2018. https://doi.org/10.1016/j.jprot.2017.07.017.
- 52.Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer. 1997;72(5):720–7. https://doi.org/10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U.PubMedCrossRefGoogle Scholar
- 53.Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res Gann. 1992;83(11):1143–9. https://doi.org/10.1111/j.1349-7006.1992.tb02737.x.PubMedCrossRefGoogle Scholar
- 61.Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360:187–95.CrossRefGoogle Scholar
- 71.Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat. 2011;130(2):587–97. https://doi.org/10.1007/s10549-011-1616-x.PubMedPubMedCentralCrossRefGoogle Scholar
- 74.Polivka J, Kralickova M, Polivka J, Kaiser C, Kuhn W, Golubnitschaja O. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J. 2017;8(2):119–27. https://doi.org/10.1007/s13167-017-0087-5.PubMedPubMedCentralCrossRefGoogle Scholar
- 79.Schottenfeld D, Jr JFF, editors. Cancer epidemiology and prevention. Third edition. Oxford: Oxford University Press; 2006. https://doi.org/10.1093/acprof:oso/9780195149616.001.0001.Google Scholar
- 88.Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14. https://doi.org/10.1093/annonc/mdu042.PubMedPubMedCentralCrossRefGoogle Scholar
- 92.Zubor P, Gondova A, Polivka J, Kasajova P, Konieczka K, Danko J, et al. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017;8(2):129–40. https://doi.org/10.1007/s13167-017-0089-3.PubMedPubMedCentralCrossRefGoogle Scholar
- 93.Bubnov R, Polivka J, Zubor P, Konieczka K, Golubnitschaja O. “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer syndrome” relevance to address the question. EPMA J. 2017;8(2):141–57. https://doi.org/10.1007/s13167-017-0092-8.PubMedPubMedCentralCrossRefGoogle Scholar
- 96.Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, et al. Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst. 2009;101(9):630–43. https://doi.org/10.1093/jnci/djp068.PubMedPubMedCentralCrossRefGoogle Scholar
- 102.Zimeri AM, Robb SW, Hassan SM, Hire RR, Davis MB. Assessing heavy metal and PCB exposure from tap water by measuring levels in plasma from sporadic breast cancer patients, a pilot study. Int J Environ Res Public Health. 2015;12(12):15683–91. https://doi.org/10.3390/ijerph121215013.PubMedPubMedCentralCrossRefGoogle Scholar
- 107.Kotepui M. Diet and risk of breast cancer. Contemp Oncol Poznan Pol. 2016;20:13–9.Google Scholar
- 114.Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan THM, et al. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev. 2015;24(2):361–8. https://doi.org/10.1158/1055-9965.EPI-14-1140.PubMedCrossRefGoogle Scholar
- 115.Xie C, Wang W, Li X, Shao N, Li W. Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature. J Matern-Fetal Neonatal Med. 2017;7:1–11.Google Scholar
- 116.Yeghiazaryan K, Cebioglu M, Golubnitschaja O. Global figures argue in favour of preventive measures and personalised treatment to optimise inadequate diabetes care. New Strateg. Adv. PreDiabetes Care Integr. Approach PPPM [Internet]. Dordrecht : Springer; 2013 [cited 2018 Jan 23]. p. 1–13. Available from: https://link.springer.com/chapter/10.1007/978-94-007-5971-8_1.
- 121.Golubnitschaja O, Debald M, Kuhn W, Yeghiazaryan K, Bubnov RV, Goncharenko VM, et al. Flammer syndrome and potential formation of pre-metastatic niches: a multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease. EPMA J. 2016;7:A25.CrossRefGoogle Scholar
- 122.Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J. 2010;1(2):263–72. https://doi.org/10.1007/s13167-010-0032-3.PubMedPubMedCentralCrossRefGoogle Scholar
- 124.Golubnitschaja O, Filep N, Yeghiazaryan K, Blom HJ, Hofmann-Apitius M, Kuhn W. Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine. Amino Acids. 2017; https://doi.org/10.1007/s00726-017-2524-0.